Although this may appear to contradict the role of RNase-L as a tumor suppressor, our lab has shown that RNase-L can have oncogenic activity in chronic myelogenous leukemia and this may contribute to that novel function in certain cell types [58]. The gene discussed is RNASEL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.